Introduction {#sec1}
============

Sulfone nucleus is a privileged structural component in a substantial number of natural products and bioactive substances.^[@ref1]^ Among them, benzothiophene dioxides possessing a cyclic sulfonyl unit have drawn considerable attention owing to their unique physical and biological activities.^[@ref2]^ For instance, benzothiophene dioxides have been found to behave as an absorbance and fluorescence switch.^[@ref3]^ Specifically, some benzothiophene dioxides could serve as inhibitors of hepatitis C virus NS5B polymerase and carbonic anhydrase.^[@ref4]^ Consequently, much effort has been made in developing general methods for the construction of benzothiophene dioxide frameworks. Most of the synthetic endeavors to assemble these compounds involve Rh-catalyzed \[2 + 2 + 2\] cycloadditions of alkynes,^[@ref5]^ photochemical cyclization of *o*-tolualdehydes,^[@ref6]^ catalytic Garratt--Braverman cyclization of dipropargyl sulfones,^[@ref7]^ Rh-catalyzed C--H insertion of α-diazo-β-arylmethanesulfonyl esters,^[@ref8]^ and Pd-catalyzed intramolecular arylations of enolates.^[@ref9]^ Recently, Wu et al. reported the insertion of sulfur dioxide into 2-alkynylaryldiazonium tetrafluoroborate^[@cit10a]^ or (2-alkynylaryl)boronic acids^[@cit10b]^ for forming benzothiophene dioxides. Despite these limited achievements, the development of facile and efficient protocols toward synthesizing new functionalized benzothiophene dioxides, starting from readily available substrates under mild conditions, is still highly desirable.

On the other hand, the insertion of sulfur dioxide into molecular skeletons has proven to be a powerful tool for the collection of biologically interesting sulfone-containing structures like sulfones and sulfonamides in a convergent manner.^[@ref11]^ Over the past few years, the pioneering work of the group of Willis^[@ref12]^ has stimulated extensive studies on the insertion of sulfur dioxide with nucleophiles (Nu) and electrophiles (E) for sulfone and sulfonamide syntheses by exploiting bench-stable solid DABCO·(SO~2~)~2~ (DABSO) as the source of sulfur dioxide ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}a).^[@ref13]^ Later, Wu and co-workers reported a three-component reaction of aryldiazonium tetrafluoroborates, DABSO, and aryl propiolates to afford 3-sulfonated coumarins ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}b).^[@ref14]^ Recently, our group has established a series of domino radical cyclizations for sulfone-containing multiple ring formations.^[@ref15]^ For example, we employed benzene-linked allene-ynes as starting materials to subject them to the reaction of aryldiazonium tetrafluoroborates and DABSO toward synthesizing sulfone-containing cyclobuta\[*a*\]naphthalen-4-ols.^[@cit15a]^ For this purpose, we considered preparing diyne-anchored starting material **1**([@ref16]) by taking advantage of a methodology in which double SO~2~ insertion across its C≡C π system results in functionalized naphtho\[1,2-*c*\]thiophene 2,2-dioxide products. As expected, this transformation proceeded smoothly under redox-neutral conditions to directly form naphtho\[1,2-*c*\]thiophene 2,2-dioxides **4** with high diastereoselectivity ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}c). Interestingly, aryldiazonium salts play dual roles as an aryl radical donor as well as an azo source, which were trapped by DABSO and 1,7-diynes, thereby simultaneously installing both sulfonyl group and azo functionality into the molecular skeleton via radical addition. The present approach represents the first radical-triggered multicomponent dehydrobicyclization cascade of 1,7-diynes for the direct synthesis of these new naphtho\[1,2-*c*\]thiophene 2,2-dioxides via double SO~2~ insertion in a one-pot manner without any additional oxidant. Herein, we elaborated this unprecedented radical dehydrobicyclization transformation.

![Profiles for S-Centered Radical Cyclization](ao-2017-01789h_0007){#sch1}

Results and Discussion {#sec2}
======================

Our initial investigation commenced with the treatment of benzene-tethered 1,7-diyne **1a** with *p*-methoxyphenyl (PMP) diazonium tetrafluoroborate (**2a**) and DABSO (**3**) in 1:2:2.5 mole ratio at 60 °C under Ar conditions using 1,2-dichloroethane (DCE) as the reaction medium. The reaction proceeded to generate naphtho\[1,2-*c*\]thiophene 2,2-dioxide **4a** bearing an unexpected azo group, albeit with a low 15% yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). Interestingly, the analysis of ^1^H NMR and X-ray diffraction of product **4a** revealed that high diastereoselectivity in 20:1 dr was observed ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). This exciting result prompted us to undertake further investigations. Because of this molecular framework incorporating two SO~2~ and two PMP units, we then adjusted the substrate ratio to 1:2:3, and the reaction provided a slightly higher yield of **4a** (27%, entry 2). The following careful screening of the substrate ratio (entries 3--6) showed that the substrate ratio 1:4:3 remarkably facilitated this reaction process and afforded a higher yield (43%). Subsequently, the effect of solvent on this transformation was investigated using various solvents such as dichloromethane (DCM), acetonitrile (CH~3~CN), 1,4-dioxane, *N*,*N*-dimethylformamide (DMF), toluene, and tetrahydrofuran (THF). The use of DCM remarkably decreased the yield to 29% (entry 7), whereas other attempted solvents completely suppressed the reaction process (entries 8--12). Elevating the reaction temperature to 70 °C was not beneficial to the transformation, accessing **4a** in a reduced yield (37%, entry 13). In contrast, a decrease of the reaction temperature could promote the conversion of 1,7-diyne **1a** into product **4a** as a higher yield (48%) was obtained with the reaction temperature being 50 °C (entry 14). Further lowering the reaction temperature to 40 °C showed no positive effect on the yield of **4a** (entry 15). To our delight, use of 0.5 equiv of Et~3~N as a base promoter efficiently facilitated this double SO~2~ insertion, delivering product **4a** in a higher yield (56%, entry 16).

![Oak Ridge thermal ellipsoid plot drawing of **4a**.](ao-2017-01789h_0005){#fig1}

###### Optimization of Reaction Conditions[a](#t1fn1){ref-type="table-fn"}

![](ao-2017-01789h_0004){#fx2}

  entry   substrate ratio                 solvent       *t* (°C)   yield (%)[b](#t1fn2){ref-type="table-fn"}
  ------- ------------------------------- ------------- ---------- -------------------------------------------
  1       1:2:2.5 (**1a**:**2a**:**3**)   DCE           60         15
  2       1:2:3 (**1a**:**2a**:**3**)     DCE           60         27
  3       1:2:4 (**1a**:**2a**:**3**)     DCE           60         ND[c](#t1fn3){ref-type="table-fn"}
  4       1:3:3 (**1a**:**2a**:**3**)     DCE           60         19
  5       1:3:4 (**1a**:**2a**:**3**)     DCE           60         trace
  6       1:4:3 (**1a**:**2a**:**3**)     DCE           60         43
  7       1:4:3 (**1a**:**2a**:**3**)     DCM           60         29
  8       1:4:3 (**1a**:**2a**:**3**)     CH~3~CN       60         trace
  9       1:4:3 (**1a**:**2a**:**3**)     1,4-dioxane   60         ND
  10      1:4:3 (**1a**:**2a**:**3**)     DMF           60         trace
  11      1:4:3 (**1a**:**2a**:**3**)     toluene       60         NR[d](#t1fn4){ref-type="table-fn"}
  12      1:4:3 (**1a**:**2a**:**3**)     THF           60         NR
  13      1:4:3 (**1a**:**2a**:**3**)     DCE           70         37
  14      1:4:3 (**1a**:**2a**:**3**)     DCE           50         48
  15      1:4:3 (**1a**:**2a**:**3**)     DCE           40         41
  16      1:4:3 (**1a**:**2a**:**3**)     DCE           50         56[e](#t1fn5){ref-type="table-fn"}

Reaction conditions: **1a**, 0.4 mmol; **2a**, *x* equiv; DABSO, *y* equiv; solvent, 2.5 mL; under Ar conditions, 1.5 h.

Isolated yield based on **1a**.

ND, not detected.

NR, no reaction.

Use of Et~3~N, 0.5 equiv.

With these acceptable reaction conditions in hand, we then systematically studied the generality of this metal-free multicomponent dehydrobicyclization cascade toward synthesizing naphtho\[1,2-*c*\]thiophene 2,2-dioxides **4** by examining 1,7-diyne and aryldiazonium tetrafluoroborate components ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). First, 1,7-diynes with different functional groups were evaluated in combination with *p*-methoxyphenyl (PMP) diazonium tetrafluoroborate (**2a**) and DABSO (**3**). Substituents bearing both electronically rich and poor properties at different positions of arylalkynyl (R^1^) moiety could be successfully engaged in this transformation, generating corresponding products **4a**--**h** with 39--67% yields and high diastereoselectivity (6:1 to 20:1 dr). Functional groups like methyl (**1b** and **1c**), ethyl (**1d**), *t*-butyl (**1e**), methoxy (**1f**), and chloride (**1g**) were tolerated with these optimal conditions, some of which needed to fine-tune the reaction temperatures. For instance, 1,7-diyne **1f** carrying a methoxy group (R^1^) was subjected to the reaction of **2a** with **3** at 30 °C, furnishing the desired product **4f** in 62% yield, whereas the presence of slight electron-withdrawing chloro group seemed to lower the efficiency of this dehydrobicyclization reaction, as the corresponding product **4g** was isolated in a decreased (39%) yield, although with a reaction temperature of 60 °C. Alternatively, 1,7-diyne **1h** with a *n*-butyl group was proven to be a suitable reaction partner, enabling the radical-induced dehydrobicyclization process toward synthesizing naphtho\[1,2-*c*\]thiophene 2,2-dioxide **4h** with 56% yield and 6:1 dr. 1,7-Diynes **1** having either electron-donating (Me, **1i**--**j** and MeO, **1k**--**m**) or -withdrawing (Cl, **1n**--**r**) substituents (R^2^) at the C4- or C5-position of the internal arene ring readily participated in the current dehydrobicyclization cascades, enabling metal-free sulfonylation and diazotization to access functionalized naphtho\[1,2-*c*\]thiophene 2,2-dioxides **4i**--**r** in 45--72% yields and 15:1 to 20:1 dr. The reaction can tolerate various aryldiazonium tetrafluoroborates **2b**--**e** with both electron-rich groups (ethoxy **2b**, dimethoxy **2c**, and methyl **2d**) at the para-position of arene ring and neutral (H, **2e**) groups, leading to the formation of naphtho\[1,2-*c*\]thiophene 2,2-dioxides **4s**--**w** with yields ranging from 43 to 62% and 10:1 to 15:1 dr. Unluckily, aryldiazonium tetrafluoroborate **2f** having a chloro group was an ineffective partner, as the reaction failed to work under standard conditions ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, **4x**). Moreover, 1,7-diyne **1k** possessing a methoxy group located at the C5-position of the internal arene ring was utilized to react with **2a** and **3**, and the corresponding product **4y** was offered in 48% yield and 10:1 dr. Similarly, ester-protected 1,7-diyne still showed high reactivity, enabling its conversion into product **4z** with 55% yield and 15:1 dr. In the case of **4a**, its stereostructure was unequivocally confirmed by carrying out single-crystal X-ray diffraction ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).

![Substrate Scope for Forming Products **4**^,,^\
Reaction conditions: **1**, 0.4 mmol; **2**, 1.6 mmol; DABSO, 1.2 mmol; Et~3~N, 0.2 mmol; DCE, 2.5 mL; 50 ^o^C, under Ar conditions, 1.5 h; isolated yields in brackets based on 1,7-diynes **1**; dr value based on their ^1^H NMR analysis.\
The reaction was conducted at 30 ^o^C.\
The reaction was conducted at 60 ^o^C.](ao-2017-01789h_0008){#sch2}

To gain more mechanistic insight into this transformation, several control experiments were performed. The presence of 3.0 equiv of 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO) or butylhydroxytoluene completely suppressed the generation of normal product **4a** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}a). Among them, a TEMPO--PMP adduct was detected by liquid chromatography--mass spectrometry (LC--MS) analysis, indicating that the reaction process might include in situ generation of aryl radicals. Treatment of **1a** with **2a** and DABSO under standard conditions resulted in **4a** in 56% yield, together with anisole **5**, 4-methoxybenzenesulfinic acid **6**, 4-methoxybenzenesulfonyl fluoride **7**, and sulfuryl difluoride ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}b), and byproducts **5**, **6**, and **7** were detected by LC--MS analysis. These results revealed that the in situ generation of aryl and arylsulfonyl radicals could abstract hydrogen atoms from 1,7-diynes to convert into the corresponding benzenes and arylsulfinic acids, and arylsulfonyl radicals act as a reduction reagent. As radical acceptors, aryldiazonium salts have previously been proven to be converted into radical cations of azo compounds via radical cross-coupling with radical species, which gain an electron to facilitate access to azo compounds through a single electron transfer (SET) process.^[@ref17]^ For this reason, we believed that during this reaction process SO~2~ serves as another reduction reagent and is oxidized and trapped by the fluoride anion to access sulfuryl difluoride ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}b), but it is difficult to be detected as it is a gas. To support the above analysis and certify the redox pathway, potassium bromide (KBr) was subjected to the reaction of **1a** with **2a** and DABSO under standard conditions ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}c). As expected, both sulfuryl dibromide **8** and sulfuryl bromide **9** were observed by LC--MS analysis. Next, in the presence of naphthalen-1-ol, the reaction gave naphthalen-1-yl sulfurofluoridate **10** (observed by LC--MS, [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}d). These results further supported the above analysis.

![Control Experiments](ao-2017-01789h_0001){#sch3}

Combining the aforementioned observations and previous reports,^[@ref13],[@ref14]^ a reasonable mechanism is proposed in [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}. The combination of aryldiazonium cations and DABSO is anticipated to give radical cation intermediates **A**, SO~2~, and aryl radicals by the homolytic cleavage of the N--S bond and a SET process.^[@ref14],[@ref18]^ Then, aryl radicals are intercepted by SO~2~ to generate arylsulfonyl radicals. Subsequently, radical addition of aryl sulfonyl radicals into 1,7-diynes **1** gives intermediates **B**,^[@ref19]^ followed by 6-exo-dig cyclization to vinyl radicals **C**,^[@ref20]^ which are trapped by SO~2~ to sulfonyl radicals **D**. Sulfonyl radicals **D** triggered 5-endo-trig cyclization, giving intermediates **E**, which undergo SET and base-promoted deprotonation to yield intermediates **G**. A subsequent hydrogen atom transfer (H-abstraction) between **G** and aryl/arylsulfonyl radicals yields benzenes/arylsulfinic acids and radical intermediates **H**, trapped by aryldiazonium cations via radical cross-coupling to afford radical cations **I**. Next, in the presence of tetrafluoroborate anions, intermediates **I** react with SO~2~ and/or aryl sulfonyl radicals via a redox process to give naphtho\[1,2-*c*\]thiophene 2,2-dioxides **J**, sulfuryl difluorides, and aryl sulfonyl fluoride.^[@cit15a]^ Intermediates **J** are converted into final products **4** through 1,3-H transfer.

![Plausible Mechanism Pathway](ao-2017-01789h_0006){#sch4}

In conclusion, we have discovered an unprecedented double SO~2~ insertion into benzene-linked 1,7-diynes under mild redox-neutral conditions, by which disulfone-containing naphtho\[1,2-*c*\]thiophene 2,2-dioxides with a wide diversity in substituents were diastereoselectively synthesized through arylsulfonyl-radical-induced 6-exo-dig/5-endo-trig bicyclization. Notably, aryldiazonium salts play dual roles as the reaction initiator as well as the reaction terminator, installing the sulfonyl group and azo functionality into the molecular skeleton via radical addition. The reaction enabled direct construction of six new σ bond including C--S, C--C, and C--N bonds by combining aryldiazonium salts, DABSO, and C(sp^3^)-linked 1,7-diynes under catalyst-free conditions, providing an easy and metal-free protocol toward synthesizing a range of richly decorated naphtho\[1,2-*c*\]thiophene 2,2-dioxides. Further investigation on mechanistic insights and its applications will be conducted in due course.

Experimental Section {#sec3}
====================

General Procedure for the Synthesis of Compounds **1** {#sec3.1}
------------------------------------------------------

![](ao-2017-01789h_0003){#fx1}

Under Ar conditions, a mixture of 2-bromobenzaldehyde (10.0 mmol), CuI (2 mol %), PdCl~2~(PPh~3~)~2~ (2 mol %), and Et~3~N (60 mL) as a solvent was stirred at 50 °C. Then, ethynylbenzene (1.05 equiv) was dropwise added into the reaction system. The resulting reaction mixture was stirred until thin-layer chromatography (TLC) indicated complete consumption of the starting material. After filtration through a pad of Celite rinsing with Et~2~O, the residue was purified by chromatography on silica gel with petroleum ether/ethyl acetate as the eluent to afford compound **I** (90--100% yield).

Under an Ar atmosphere, a mixture of compound **I** (5.0 mmol, 1.0 equiv), 3-bromoprop-1-yne (1.5 equiv), and zinc powder (4 equiv) in 60 mL of THF/DMF (1/1) was stirred at room temperature, and the reaction system was detected by TLC. After completion of the reaction, the residue was quenched with saturated NH~4~Cl solution, extracted with ethyl acetate, and dried on MgSO~4~. After removal of the solvent, the crude product was purified by column chromatography (EtOAc/hexanes, 1:10) to give compound **II** as a white solid (80--90% yield).

To a solution of compound **II** (4.0 mmol, 1.0 equiv) in anhydrous THF (20 mL), NaH (2.0 equiv) was added dropwise at 0 °C. After stirring for 0.5 h, CH~3~I (1.2 equiv) was added and then the reaction mixture was stirred at room temperature. After the mixture was stirred overnight, the reaction mixture was quenched with saturated NH~4~Cl solution, extracted with ethyl acetate, and dried on MgSO~4~. After removal of the solvent, the crude product was purified by column chromatography (EtOAc/hexanes, 1:100) to give compound **1** (oil, 80--95% yield).

Synthesis of Compound **1s** {#sec3.2}
----------------------------

To a solution of compound **II** (4.0 mmol, 1.0 equiv), pyridine (3.0 equiv), and 4-dimethylaminopyridine (20 mol %) in anhydrous dichloromethane (15 mL) at 0 °C was slowly added Ac~2~O (2 equiv). The reaction mixture was stirred for 6 h, and then 20 mL of saturated aqueous sodium bicarbonate was added. The aqueous layer was extracted with dichloromethane, and the combined organic layer was dried over MgSO~4~ and concentrated in vacuo. Purification by flash chromatography delivered **1z** (oil, 75--80% yield).

### 1-(1-Methoxybut-3-yn-1-yl)-2-(phenylethynyl)benzene (**1a**) {#sec3.2.1}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.68--7.63 (m, 3H), 7.61 (d, *J* = 1.2 Hz, 1H), 7.46--7.41 (m, 4H), 7.36--7.32 (m, 1H), 5.12--5.07 (m, 1H), 3.44 (s, 3H), 2.92--2.86 (m, 1H), 2.80--2.73 (m, 1H), 2.19--2.06 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 142.4, 132.2, 131.6, 128.8, 128.6(3), 128.6(6), 127.7, 125.7, 123.1, 122.0, 95.0, 86.9, 81.1, 79.5, 70.1, 57.5, 27.0.

### 1-(1-Methoxybut-3-yn-1-yl)-2-(*p*-tolylethynyl)benzene (**1b**) {#sec3.2.2}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.63--7.59 (m, 2H), 7.55 (d, *J* = 8.4 Hz, 2H), 7.46--7.41 (m, 1H), 7.36--7.31 (m, 1H), 7.23 (d, *J* = 8.0 Hz, 2H), 5.16--5.01 (m, 1H), 3.44 (s, 3H), 2.92--2.83 (m, 1H), 2.80--2.71 (m, 1H), 2.43 (s, 3H), 2.16--2.06 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 142.3, 138.7, 132.1, 131.5, 129.3, 128.6, 127.6, 125.7, 122.2, 120.1, 95.2, 86.2, 81.1, 79.5, 69.9, 57.5, 27.0, 21.6.

### 1-(1-Methoxybut-3-yn-1-yl)-2-(*m*-tolylethynyl)benzene (**1c**) {#sec3.2.3}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.57 (d, *J* = 8.0 Hz, 2H), 7.45--7.40 (m, 3H), 7.35--7.28 (m, 2H), 7.21 (d, *J* = 7.6 Hz, 1H), 5.05--5.01 (m, 1H), 3.41 (s, 3H), 2.88--2.81 (m, 1H), 2.74--2.67 (m, 1H), 2.41 (s, 3H), 2.10--2.02 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 142.2, 138.2, 132.1, 129.5, 128.6(4), 128.6(2), 128.4, 127.6, 125.6, 122.9, 122.0, 95.1, 86.4, 81.0, 79.4, 69.8, 57.5, 26.9, 21.3.

### 1-((4-Ethylphenyl)ethynyl)-2-(1-methoxybut-3-yn-1-yl)benzene (**1d**) {#sec3.2.4}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.53 (d, *J* = 8.0 Hz, 2H), 7.50--7.47 (m, 2H), 7.40--7.36 (m, 1H), 7.31--7.26 (m, 1H), 7.21 (d, *J* = 8.0 Hz, 2H), 5.00--4.96 (m, 1H), 3.37 (s, 3H), 2.83--2.76 (m, 1H), 2.71--2.67 (m, 2H), 2.67--2.61 (m, 1H), 2.04--2.00 (m, 1H), 1.26 (t, *J* = 7.6 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 145.0, 142.1, 132.0, 131.5, 128.5, 128.0, 127.5, 125.6, 122.1, 120.2, 95.1, 86.0, 81.0, 79.3, 69.7, 57.5, 28.9, 26.9, 15.4.

### 1-((4-(*tert*-Butyl)phenyl)ethynyl)-2-(1-methoxybut-3-yn-1-yl)benzene (**1e**) {#sec3.2.5}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.61--7.49 (m, 4H), 7.47--7.36 (m, 3H), 7.35--7.29 (m, 1H), 5.09--4.94 (m, 1H), 3.39 (s, 3H), 2.86--2.77 (m, 1H), 2.73--2.64 (m, 1H), 2.08--2.01 (m, 1H), 1.37 (s, 9H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 151.9, 142.2, 132.0, 131.3, 128.5, 127.5, 125.6, 125.5, 122.1, 120.0, 95.0, 86.0, 81.0, 79.3, 69.7, 57.5, 34.8, 31.2, 26.9.

### 1-(1-Methoxybut-3-yn-1-yl)-2-((4-methoxyphenyl)ethynyl)benzene (**1f**) {#sec3.2.6}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.55--7.51 (m, 4H), 7.41--7.37 (m, 1H), 7.33--7.28 (m, 1H), 6.93 (d, *J* = 8.8 Hz, 2H), 5.02--4.98 (m, 1H), 3.87 (s, 3H), 3.39 (s, 3H), 2.85--2.79 (m, 1H), 2.71--2.64 (m, 1H), 2.06--2.03 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 159.8, 142.0, 133.0, 131.9, 128.3, 127.5, 125.5, 122.2, 115.1, 114.1, 94.9, 85.4, 81.1, 79.4, 69.7, 57.5, 55.4, 26.9.

### 1-((4-Chlorophenyl)ethynyl)-2-(1-methoxybut-3-yn-1-yl)benzene (**1g**) {#sec3.2.7}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.55 (d, *J* = 7.6 Hz, 2H), 7.53--7.50 (m, 2H), 7.45--7.41 (m, 1H), 7.39--7.36 (m, 2H), 7.34--7.30 (m, 1H), 4.98--4.95 (m, 1H), 3.39 (s, 3H), 2.83--2.77 (m, 1H), 2.71--2.65 (m, 1H), 2.05--2.04 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 141.3, 133.5, 131.7, 131.1, 127.9, 127.8, 126.6, 124.6, 120.5, 120.5, 92.6, 86.6, 79.9, 78.4, 68.8, 56.4, 25.9.

### 1-(Hex-1-yn-1-yl)-2-(1-methoxybut-3-yn-1-yl)benzene (**1h**) {#sec3.2.8}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.48 (d, *J* = 8.0 Hz, 1H), 7.41 (d, *J* = 7.6 Hz, 1H), 7.35--7.30 (m, 1H), 7.25--7.20 (m, 1H), 4.92--4.87 (m, 1H), 3.34 (s, 3H), 2.75--2.69 (m, 1H), 2.63--2.56 (m, 1H), 2.50--2.46 (m, 2H), 2.03--2.00 (m, 1H), 1.68--1.61 (m, 2H), 1.58--1.50 (m, 2H), 0.99 (t, *J* = 7.4 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 142.0, 132.1, 127.8, 127.4, 125.4, 122.7, 96.0, 81.1, 79.2, 78.0, 69.5, 57.3, 30.8, 26.8, 22.1, 19.2, 13.6.

### 1-(1-Methoxybut-3-yn-1-yl)-4-methyl-2-(*p*-tolylethynyl)benzene (**1i**) {#sec3.2.9}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.51 (d, *J* = 8.0 Hz, 2H), 7.47 (d, *J* = 8.0 Hz, 1H), 7.41 (s, 1H), 7.25--7.21 (m, 3H), 5.04--5.00 (m, 1H), 3.41 (s, 3H), 2.87--2.80 (m, 1H), 2.75--2.68 (m, 1H), 2.43 (s, 3H), 2.40 (s, 3H), 2.08--2.06 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 139.2, 138.6, 137.3, 132.5, 131.5, 129.5, 129.2, 125.6, 122.0, 120.1, 94.7, 86.3, 81.2, 79.2, 69.8, 57.4, 27.0, 21.6, 21.0.

### 2-((4-Chlorophenyl)ethynyl)-1-(1-methoxybut-3-yn-1-yl)-4-methylbenzene (**1j)** {#sec3.2.10}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.52--7.48 (m, 2H), 7.43 (d, *J* = 8.0 Hz, 1H), 7.39--7.35 (m, 3H), 7.24 (d, *J* = 7.6 Hz, 1H), 4.95--4.91 (m, 1H), 3.37 (s, 3H), 2.80--2.73 (m, 1H), 2.70--2.63 (m, 1H), 2.38 (s, 3H), 2.06--2.01 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 139.3, 137.4, 134.5, 132.7, 132.6, 129.9, 128.8, 125.6, 121.6, 121.5, 93.2, 87.9, 81.0, 79.2, 69.7, 57.4, 27.0, 20.9.

### 4-Methoxy-2-(1-methoxybut-3-yn-1-yl)-1-(phenylethynyl)benzene (**1k**) {#sec3.2.11}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.56 (m, 2H), 7.49 (d, *J* = 8.4 Hz, 1H), 7.42--7.36 (m, 3H), 7.11 (d, *J* = 2.8 Hz, 1H), 6.88--6.84 (m, 1H), 4.99--4.95 (m, 1H), 3.88 (s, 3H), 3.41 (s, 3H), 2.85--2.79 (m, 1H), 2.70--2.63 (m, 1H), 2.10--2.04 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 160.1, 144.2, 133.5, 131.4, 128.4, 128.2, 123.4, 113.9, 113.7, 110.8, 93.5, 86.7, 80.9, 79.3, 69.8, 57.6, 55.4, 26.9.

### 4-Methoxy-2-(1-methoxybut-3-yn-1-yl)-1-(*p*-tolylethynyl)benzene (**1l**) {#sec3.2.12}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.50--7.42 (m, 3H), 7.19 (d, *J* = 8.0 Hz, 2H), 7.10 (d, *J* = 2.8 Hz, 1H), 6.87--6.83 (m, 1H), 4.99--4.95 (m, 1H), 3.87 (s, 3H), 3.41 (s, 3H), 2.85--2.79 (m, 1H), 2.69--2.62 (m, 1H), 2.40 (s, 3H), 2.08--2.03 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 159.9, 144.1, 138.3, 133.4, 131.2, 129.2, 120.3, 114.2, 113.7, 110.8, 93.7, 86.0, 81.0, 79.3, 69.8, 57.6, 55.4, 26.8, 21.5.

### 1-((4-Chlorophenyl)ethynyl)-4-methoxy-2-(1-methoxybut-3-yn-1-yl)benzene **(1m**) {#sec3.2.13}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.50--7.46 (m, 3H), 7.37--7.33 (m, 2H), 7.10 (d, *J* = 2.8 Hz, 1H), 6.88--6.84 (m, 1H), 4.95--4.91 (m, 1H), 3.88 (s, 3H), 3.40 (s, 3H), 2.83--2.76 (m, 1H), 2.69--2.61 (m, 1H), 2.07--2.04 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 160.3, 144.3, 134.1, 133.6, 132.5, 128.7, 121.9, 113.7, 113.6, 110.9, 92.4, 87.7, 80.9, 79.4, 69.8, 57.6, 55.4, 26.9.

### 4-Chloro-2-(1-methoxybut-3-yn-1-yl)-1-(phenylethynyl)benzene (**1n**) {#sec3.2.14}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.59--7.54 (m, 3H), 7.49 (d, *J* = 8.4 Hz, 1H), 7.42--7.38 (m, 3H), 7.31--7.29 (m, 1H), 4.96--4.92 (m, 1H), 3.41 (s, 3H), 2.84--2.77 (m, 1H), 2.71--2.64 (m, 1H), 2.08--2.04 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 144.2, 134.9, 133.3, 131.5, 128.8, 128.5, 127.9, 126.1, 122.7, 120.3, 95.7, 85.6, 80.4, 79.0, 70.1, 57.7, 26.7.

### 4-Chloro-2-(1-methoxybut-3-yn-1-yl)-1-(*p*-tolylethynyl)benzene (**1o**) {#sec3.2.15}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.54 (d, *J* = 2.0 Hz, 1H), 7.49--7.45 (m, 3H), 7.30--7.27 (m, 1H), 7.21 (d, *J* = 8.0 Hz, 2H), 4.97--4.92 (m, 1H), 3.40 (s, 3H), 2.84--2.77 (m, 1H), 2.70--2.63 (m, 1H), 2.41 (s, 3H), 2.07--2.04 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 144.1, 139.0, 134.6, 133.2, 131.4, 129.3, 127.9, 126.0, 120.5, 119.6, 96.0, 85.0, 80.5, 79.0, 70.1, 57.7, 26.7, 21.6.

### 4-Chloro-1-((4-ethylphenyl)ethynyl)-2-(1-methoxybut-3-yn-1-yl)benzene (**1p**) {#sec3.2.16}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.54 (d, *J* = 2.0 Hz, 1H), 7.51--7.46 (m, 3H), 7.30--7.27 (m, 1H), 7.24 (d, *J* = 8.0 Hz, 2H), 4.96--4.92 (m, 1H), 3.40 (s, 3H), 2.84--2.77 (m, 1H), 2.73--2.69 (m, 2H), 2.68--2.63 (m, 1H), 2.07--2.05 (m, 1H), 1.28 (t, *J* = 7.6 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 145.3, 144.1, 134.6, 133.2, 131.5, 128.1, 127.9, 126.0, 120.5, 119.8, 96.0, 85.0, 80.4, 79.0, 70.1, 57.7, 28.9, 26.7, 15.4.

### 1-((4-(*tert*-Butyl)phenyl)ethynyl)-4-chloro-2-(1-methoxybut-3-yn-1-yl)benzene (**1q**) {#sec3.2.17}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.55--7.49 (m, 3H), 7.47 (d, *J* = 8.4 Hz, 1H), 7.42 (d, *J* = 8.4 Hz, 2H), 7.30--7.27 (m, 1H), 4.96--4.92 (m, 1H), 3.40 (s, 3H), 2.83--2.76 (m, 1H), 2.70--2.62 (m, 1H), 2.06--2.05 (m, 1H), 1.36 (s, 9H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 152.2, 144.1, 134.6, 133.2, 131.3, 127.9, 126.0, 125.5, 120.5, 119.7, 95.9, 85.0, 80.4, 79.0, 70.1, 57.7, 34.9, 31.2, 26.6.

### 4-Chloro-2-(1-methoxybut-3-yn-1-yl)-1-((4-methoxyphenyl)ethynyl)benzene (**1r**) {#sec3.2.18}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.56--7.49 (m, 3H), 7.46 (d, *J* = 8.4 Hz, 1H), 7.29--7.26 (m, 1H), 6.96--6.90 (m, 2H), 4.95--4.91 (m, 1H), 3.86 (s, 3H), 3.40 (s, 3H), 2.84--2.77 (m, 1H), 2.69--2.63 (m, 1H), 2.07--2.05 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 160.0, 143.9, 134.4, 133.1, 133.0, 127.9, 126.0, 120.7, 114.8, 114.2, 95.9, 84.4, 80.5, 79.1, 70.1, 57.7, 55.4, 26.7.

### 1-(2-(Phenylethynyl)phenyl)but-3-yn-1-yl acetate (**1s**) {#sec3.2.19}

White oil; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.64--7.57 (m, 3H), 7.54 (d, *J* = 7.6 Hz, 1H), 7.42--7.38 (m, 4H), 7.36--7.32 (m, 1H), 6.51--6.47 (m, 1H), 3.03--2.97 (m, 1H), 2.92--2.85 (m, 1H), 2.20 (s, 3H), 2.05--2.03 (m, 1H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 169.9, 140.6, 132.3, 131.6, 128.6, 128.5, 128.4, 128.0, 125.8, 123.0, 121.4, 95.3, 86.4, 79.5, 71.7, 70.7, 25.3, 21.1.

General Procedure for the Synthesis of Products **4** {#sec3.3}
-----------------------------------------------------

Example for the synthesis of **4a**: To a 25 mL Schlenk tube under Ar conditions, 1-(1-methoxybut-3-yn-1-yl)-2-(phenylethynyl)benzene (**1a**, 0.4 mmol, 104 mg, 1.0 equiv), 1,4-diazabicyclo\[2.2.2\]octane bis(sulfur dioxide) adduct (**3**, 1.2 mmol, 288 mg, 3.0 equiv), 4-methoxybenzenediazonium tetrafluoroborate (**2a**, 1.6 mmol, 355 mg, 4.0 equiv), triethylamine (0.2 mmol, 20 mg, 0.5 equiv), and 1,2-dichloroethane (2.5 mL) were successively added. Then, the tube was stirred at 50 °C for 1.5 h until complete consumption of **1a**, as monitored by TLC analysis. After the reaction was completed, the reaction mixture was concentrated in vacuum and the resulting residue was purified by column chromatography on silica gel (eluent, petroleum ether/ethyl acetate = 3:1) to afford the desired product **4a** as a red solid.

### (*E*)-5-Methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-1-phenyl-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4a**, Major) {#sec3.3.1}

141 mg, 56%; red solid, mp 153--154 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.81 (d, *J* = 8.8 Hz, 2H), 7.71--7.46 (m, 9H), 7.19 (s, 2H), 7.06 (d, *J* = 8.4 Hz, 2H), 6.60 (d, *J* = 8.8 Hz, 2H), 6.36 (s, 1H), 5.92 (s, 1H), 3.97 (s, 3H), 3.60 (s, 3H), 3.12 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 163.5, 148.1, 147.0, 138.7, 136.5, 135.8, 132.3, 131.1, 130.7(4), 130.7(8), 130.5, 129.8, 129.4, 128.3, 128.1, 127.7, 127.2, 126.3, 126.1, 114.3, 114.0, 69.2, 55.8, 55.5, 54.2. IR (film, ν, cm^--1^) 2933, 2840, 1595, 1577, 1498, 1337, 1146, 838. HR-MS (ESI) *m*/*z* calcd for C~33~H~28~N~2~NaO~7~S~2~ \[M + Na\]^+^ 651.1236, found 651.1237.

### (*E*)-5-Methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-1-(*p*-tolyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4b**, Major) {#sec3.3.2}

149 mg, 58%; red solid, mp 188--189 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.81 (d, *J* = 8.8 Hz, 2H), 7.67--7.60 (m, 3H), 7.53--7.46 (m, 3H), 7.32 (d, *J* = 8.0 Hz, 2H), 7.25 (d, *J* = 8.0 Hz, 1H), 7.22--7.16 (m, 1H), 7.05 (d, *J* = 9.2 Hz, 2H), 6.59 (d, *J* = 8.8 Hz, 2H), 6.35 (s, 1H), 5.92 (s, 1H), 3.96 (s, 3H), 3.60 (s, 3H), 3.11 (s, 3H), 2.46 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 163.4, 147.9, 147.0, 141.2, 139.0, 136.1, 135.7, 132.2, 131.0, 130.7, 130.4, 130.2, 130.0, 128.3, 128.2, 127.7, 127.3, 126.0, 123.2, 114.3, 114.0, 69.2, 55.8, 55.5, 54.2, 21.6. IR (film, ν, cm^--1^) 2934, 2855, 1594, 1497, 1336, 1145, 831. HR-MS (ESI) *m*/*z* calcd for C~34~H~30~N~2~NaO~7~S~2~ \[M + Na\]^+^ 665.1392, found 665.1387.

### (*E*)-5-Methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-1-(*m*-tolyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4c**, Major) {#sec3.3.3}

164 mg, 64%; red solid, mp 182--183 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.80 (d, *J* = 8.8 Hz, 2H), 7.67--7.61 (m, 3H), 7.52--7.48 (m, 1H), 7.44--7.35 (m, 4H), 7.24--7.16 (m, 2H), 7.05 (d, *J* = 8.8 Hz, 2H), 6.60 (d, *J* = 9.2 Hz, 2H), 6.36 (s, 1H), 5.91 (s, 1H), 3.96 (s, 3H), 3.60 (s, 3H), 3.11 (s, 3H), 2.43 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 163.5, 148.0, 147.0, 139.3, 139.0, 136.3, 135.7, 132.2, 131.6, 131.1, 130.8, 130.6, 129.9, 129.3, 128.3, 128.2, 127.8, 127.6, 127.2, 126.2, 126.1, 114.3, 114.0, 69.2, 55.8, 55.5, 54.2, 21.4. IR (film, ν, cm^--1^) 2929, 2844, 1593, 1577, 1498, 1334, 1255, 1149, 838. HR-MS (ESI) *m*/*z* calcd for C~34~H~30~N~2~NaO~7~S~2~ \[M + Na\]^+^ 665.1392, found 665.1390.

### (*E*)-1-(4-Ethylphenyl)-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4d**, Major) {#sec3.3.4}

160 mg, 61%; red solid, mp 171--172 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.81 (d, *J* = 8.8 Hz, 2H), 7.67--7.61 (m, 3H), 7.53--7.47 (m, 3H), 7.34 (d, *J* = 8.0 Hz, 2H), 7.26 (d, *J* = 7.6 Hz, 1H), 7.21--7.16 (m, 1H), 7.05 (d, *J* = 9.2 Hz, 2H), 6.59 (d, *J* = 8.8 Hz, 2H), 6.35 (s, 1H), 5.92 (s, 1H), 3.96 (s, 3H), 3.60 (s, 3H), 3.12 (s, 3H), 2.79--2.73 (m, 2H), 1.31 (t, *J* = 7.6 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 163.5, 147.9, 147.3, 147.0, 139.0, 136.1, 135.7, 132.2, 131.0, 130.7, 130.4, 130.0, 129.0, 128.3, 128.2, 127.7, 127.2, 127.1, 126.1, 123.4, 114.3, 114.0, 69.2, 55.8, 55.5, 54.2, 28.9, 15.2. IR (film, ν, cm^--1^) 2965, 2839, 1594, 1577, 1496, 1332, 1260, 1145, 829. HR-MS (ESI) *m*/*z* calcd for C~35~H~32~N~2~NaO~7~S~2~ \[M + Na\]^+^ 679.1549, found 679.1552.

### (*E*)-1-(4-(*tert*-Butyl)phenyl)-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4e**, Major) {#sec3.3.5}

183 mg, 67%; red solid, mp 172--173 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.81 (d, *J* = 8.8 Hz, 2H), 7.67--7.61 (m, 3H), 7.55--7.47 (m, 5H), 7.27--7.18 (m, 2H), 7.05 (d, *J* = 9.2 Hz, 2H), 6.59 (d, *J* = 8.8 Hz, 2H), 6.36 (s, 1H), 5.93 (s, 1H), 3.96 (s, 3H), 3.60 (s, 3H), 3.11 (s, 3H), 1.39 (s, 9H). ^13^C NMR (100 MHz, DMSO-*d*~6~; δ, ppm) 164.2, 163.7, 154.2, 148.3, 146.9, 138.6, 136.6, 136.0, 132.2, 131.7, 131.5, 130.2, 130.1, 128.9, 127.9, 127.2, 127.1, 127.0, 123.6, 114.9, 114.7, 76.7, 69.1, 56.4, 55.9, 55.1, 35.3, 31.4. IR (film, ν, cm^--1^) 2964, 2846, 1617, 1595, 1407, 1326, 1145, 838. HR-MS (ESI) *m*/*z* calcd for C~37~H~36~N~2~NaO~7~S~2~ \[M + Na\]^+^ 707.1862, found 707.1863.

### (*E*)-5-Methoxy-1-(4-methoxyphenyl)-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4f**) {#sec3.3.6}

163 mg, 62%; red solid, mp 157--158 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.81 (d, *J* = 8.8 Hz, 2H), 7.65--7.61 (m, 3H), 7.56 (d, *J* = 8.8 Hz, 2H), 7.52--7.47 (m, 1H), 7.23--7.18 (m, 1H), 7.07--7.02 (m, 5H), 6.59 (d, *J* = 8.8 Hz, 2H), 6.35 (s, 1H), 5.91 (s, 1H), 3.96 (s, 3H), 3.91 (s, 3H), 3.60 (s, 3H), 3.12 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 163.4, 161.7, 147.8, 147.1, 138.7, 135.7, 132.2, 132.0, 130.9, 130.7, 130.0, 128.4, 128.2, 127.6, 127.3, 126.0, 118.1, 115.0, 114.3, 114.0, 69.3, 55.8, 55.5, 55.4, 54.2. IR (film, ν, cm^--1^) 2933, 2842, 1600, 1578, 1499, 1322, 1257, 1146, 836. HR-MS (ESI) *m*/*z* calcd for C~34~H~30~N~2~NaO~8~S~2~ \[M + Na\]^+^ 681.1341, found 681.1342.

### (*E*)-1-(4-Chlorophenyl)-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4g**, Major) {#sec3.3.7}

103 mg, 39%; red solid, mp 181--182 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.83--7.78 (m, 2H), 7.67--7.61 (m, 3H), 7.59--7.50 (m, 5H), 7.25--7.18 (m, 2H), 7.06 (d, *J* = 9.2 Hz, 2H), 6.60 (d, *J* = 8.8 Hz, 2H), 6.35 (s, 1H), 5.89 (s, 1H), 3.97 (s, 3H), 3.60 (s, 3H), 3.14 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.4, 163.6, 148.5, 147.0, 137.3, 137.2, 137.0, 135.9, 132.2, 131.9, 131.3, 130.8, 129.8, 129.5, 128.4, 127.9, 127.7, 127.2, 126.1, 124.8, 114.3, 114.0, 69.3, 55.8, 55.5, 54.5. IR (film, ν, cm^--1^) 2989, 2866, 1617, 1598, 1323, 1263, 1146, 835. HR-MS (ESI) *m*/*z* calcd for C~33~H~27~ClN~2~NaO~7~S~2~ \[M + Na\]^+^ 685.0846, found 685.0847.

### (*E*)-1-Butyl-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4h**, Major) {#sec3.3.8}

136 mg, 56%; red solid, mp 168--169 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.80--7.74 (m, 2H), 7.71--7.66 (m, 2H), 7.60--7.54 (m, 3H), 7.06--7.01 (m, 2H), 6.98--6.78 (m, 1H), 6.57 (d, *J* = 8.8 Hz, 2H), 6.24 (s, 1H), 5.89 (s, 1H), 3.95 (s, 3H), 3.60 (s, 3H), 3.02 (s, 3H), 2.94--2.88 (m, 2H), 2.00--1.90 (m, 1H), 1.77--1.67 (m, 1H), 1.57--1.51 (m, 2H), 1.03 (d, *J* = 7.2 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 163.3, 147.1, 147.0, 141.6, 135.8, 135.5, 132.2, 131.0, 130.8, 130.7, 128.9, 128.8, 127.7, 127.2, 127.0, 125.9, 114.5, 114.2, 113.9, 113.5, 69.2, 55.8, 55.4, 54.0, 30.5, 25.0, 23.1, 13.7. IR (film, ν, cm^--1^) 2940, 2870, 1596, 1577, 1499, 1336, 1256, 1140, 836. HR-MS (ESI) *m*/*z* calcd for C~31~H~32~N~2~NaO~7~S~2~ \[M + Na\]^+^ 631.1549, found 631.1552.

### (*E*)-5-Methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-8-methyl-1-(*p*-tolyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4i**, Major) {#sec3.3.9}

165 mg, 63%; red solid, mp 166--167 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.78 (d, *J* = 8.8 Hz, 2H), 7.62 (d, *J* = 8.8 Hz, 2H), 7.54--7.48 (m, 3H), 7.32 (d, *J* = 8.0 Hz, 3H), 7.04 (d, *J* = 8.4 Hz, 3H), 6.61--6.55 (m, 2H), 6.34 (s, 1H), 5.87 (s, 1H), 3.95 (s, 3H), 3.58 (s, 3H), 3.09 (s, 3H), 2.47 (s, 3H), 2.15 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 163.4, 148.0, 147.0, 141.1, 138.7, 138.1, 136.3, 132.8, 132.2, 131.9, 130.5, 130.4, 130.1, 130.0, 128.2, 128.1, 127.2, 126.0, 123.3, 114.3, 114.0, 68.9, 55.8, 55.4, 53.9, 21.6, 21.2. IR (film, ν, cm^--1^) 2950, 2843, 1595, 1577, 1496, 1335, 1255, 1148, 847. HR-MS (ESI) *m*/*z* calcd for C~35~H~32~N~2~NaO~7~S~2~ \[M + Na\]^+^ 679.1549, found 679.1547.

### (*E*)-1-(4-Chlorophenyl)-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-8-methyl-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4j**, Major) {#sec3.3.10}

127 mg, 47%; red solid, mp 180--181 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.78 (d, *J* = 8.8 Hz, 2H), 7.64--7.58 (m, 4H), 7.54--7.50 (m, 3H), 7.34--7.31 (m, 1H), 7.07--7.00 (m, 3H), 6.59 (d, *J* = 8.8 Hz, 2H), 6.34 (s, 1H), 5.84 (s, 1H), 3.96 (s, 3H), 3.59 (s, 3H), 3.11 (s, 3H), 2.18 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 163.6, 148.5, 147.0, 138.3, 137.2, 137.1, 133.0, 132.2, 132.1, 132.0, 130.6, 129.7, 128.1, 127.8, 127.1, 126.1, 125.0, 114.3, 114.0, 69.0, 55.8, 55.4, 54.3, 21.3. IR (film, ν, cm^--1^) 2991, 2927, 1597, 1576, 1496, 1335, 1264, 1146, 834. HR-MS (ESI) *m*/*z* calcd for C~34~H~29~ClN~2~NaO~7~S~2~ \[M + Na\]^+^ 699.1002, found 699.1022.

### (*E*)-5,7-Dimethoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-1-phenyl-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4k**, Major) {#sec3.3.11}

179 mg, 68%; red solid, mp 171--172 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.81 (d, *J* = 8.8 Hz, 2H), 7.65 (d, *J* = 9.2 Hz, 2H), 7.59--7.49 (m, 5H), 7.14--7.10 (m, 2H), 7.05 (d, *J* = 9.2 Hz, 2H), 6.73--6.70 (m, 1H), 6.61 (d, *J* = 9.2 Hz, 2H), 6.35 (s, 1H), 5.90 (s, 1H), 3.96 (s, 3H), 3.88 (s, 3H), 3.61 (s, 3H), 3.09 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 163.5, 161.7, 147.8, 147.0, 137.8, 136.7, 136.3, 132.2, 130.6, 130.5, 130.1, 129.4, 129.3, 127.3, 126.6, 126.0, 120.6, 115.1, 114.7, 114.3, 114.0, 69.2, 55.8, 55.5, 55.5, 53.8. IR (film, ν, cm^--1^) 2958, 2842, 1595, 1499, 1442, 1323, 1254, 1145, 1024, 833. HR-MS (ESI) *m*/*z* calcd for C~34~H~30~N~2~NaO~8~S~2~ \[M + Na\]^+^ 681.1341, found 681.1345.

### (*E*)-5,7-Dimethoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-1-(*p*-tolyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4l**, Major) {#sec3.3.12}

193 mg, 72%; red solid, mp 189--190 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.83--7.78 (m, 2H), 7.67--7.62 (m, 2H), 7.47 (d, *J* = 8.0 Hz, 2H), 7.31 (d, *J* = 8.0 Hz, 2H), 7.18 (d, *J* = 8.8 Hz, 1H), 7.13 (d, *J* = 2.8 Hz, 1H), 7.05 (d, *J* = 9.2 Hz, 2H), 6.75--6.71 (m, 1H), 6.61 (d, *J* = 9.2 Hz, 2H), 6.34 (s, 1H), 5.90 (s, 1H), 3.96 (s, 3H), 3.88 (s, 3H), 3.61 (s, 3H), 3.09 (s, 3H), 2.46 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 163.4, 161.7, 147.6, 147.0, 140.9, 137.7, 137.0, 136.0, 132.2, 130.4, 130.2, 130.1, 129.3, 127.2, 126.0, 123.5, 120.7, 115.1, 114.7, 114.3, 114.0, 69.2, 55.8, 55.5(1), 55.5(8), 53.8, 21.6. IR (film, ν, cm^--1^) 2964, 2841, 1597, 1576, 1495, 1331, 1256, 1147, 1023, 836. HR-MS (ESI) *m*/*z* calcd for C~35~H~32~N~2~NaO~8~S~2~ \[M + Na\]^+^ 695.1498, found 695.1500.

### (*E*)-1-(4-Chlorophenyl)-5,7-dimethoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4m**, Major) {#sec3.3.13}

147 mg, 53%; red solid, mp 185--186 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.79 (d, *J* = 9.2 Hz, 2H), 7.63 (d, *J* = 8.8 Hz, 2H), 7.57--7.49 (m, 4H), 7.15--7.12 (m, 2H), 7.05 (d, *J* = 8.8 Hz, 2H), 6.78--6.74 (m, 1H), 6.60 (d, *J* = 9.2 Hz, 2H), 6.34 (s, 1H), 5.86 (s, 1H), 3.96 (s, 3H), 3.89 (s, 3H), 3.59 (s, 3H), 3.10 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 163.6, 161.9, 148.1, 147.0, 138.0, 137.0, 136.8, 135.3, 132.2, 132.0, 129.8, 129.3, 127.1, 126.1, 125.1, 120.2, 115.4, 114.7, 114.3, 114.0, 69.3, 55.8, 55.6, 55.5, 54.1. IR (film, ν, cm^--1^) 2948, 2938, 1596, 1577, 1497, 1332, 1257, 1148, 837. HR-MS (ESI) *m*/*z* calcd for C~34~H~29~ClN~2~NaO~8~S~2~ \[M + Na\]^+^ 715.0952, found 715.0957.

### (*E*)-7-Chloro-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-1-phenyl-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4n**, Major) {#sec3.3.14}

119 mg, 45%; red solid, mp 177--178 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.80 (d, *J* = 8.8 Hz, 2H), 7.66--7.62 (m, 3H), 7.61--7.52 (m, 5H), 7.18--7.12 (m, 2H), 7.06 (d, *J* = 8.8 Hz, 2H), 6.62 (d, *J* = 8.8 Hz, 2H), 6.34 (s, 1H), 5.87 (s, 1H), 3.97 (s, 3H), 3.61 (s, 3H), 3.14 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.4, 163.7, 147.8, 147.0, 139.1, 137.6, 137.2, 135.5, 132.2, 130.9, 130.6, 130.5, 129.5, 128.9, 128.7, 127.2, 126.6, 126.1(3), 126.1(7), 114.4, 114.1, 69.0, 55.8, 55.5, 54.6. IR (film, ν, cm^--1^) 2940, 1842, 1616, 1593, 1497, 1263, 1145, 837. HR-MS (ESI) *m*/*z* calcd for C~33~H~27~ClN~2~NaO~7~S~2~ \[M + Na\]^+^ 685.0846, found 685.0842.

### (*E*)-7-Chloro-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-1-(*p*-tolyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4o**, Major) {#sec3.3.15}

130 mg, 48%; red solid, mp 225--226 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 8.43 (d, *J* = 2.0 Hz, 1H), 7.91 (d, *J* = 8.8 Hz, 2H), 7.62 (d, *J* = 9.2 Hz, 3H), 7.36 (s, 1H), 7.32--7.22 (m, 3H), 7.11 (d, *J* = 8.8 Hz, 3H), 6.81 (d, *J* = 8.8 Hz, 3H), 6.30 (s, 1H), 4.24 (s, 3H), 3.98 (s, 3H), 3.84 (s, 3H), 2.41 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.6, 163.0, 153.5, 147.0, 140.1, 137.4, 134.4, 132.2, 131.9, 131.7, 131.0, 130.4, 129.8, 129.1, 128.7, 128.5, 127.9, 125.0, 124.9, 123.7, 119.1, 114.5, 114.1, 80.0, 69.1, 64.9, 55.8, 21.4. IR (film, ν, cm^--1^) 2960, 2835, 1637, 1616, 1593, 1500, 1338, 1257, 1145, 834. HR-MS (ESI) *m*/*z* calcd for C~34~H~29~ClN~2~NaO~7~S~2~ \[M + Na\]^+^ 699.1002, found 699.1003.

### (*E*)-7-Chloro-1-(4-ethylphenyl)-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4p**, Major) {#sec3.3.16}

152 mg, 55%; red solid, mp 177--178 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.79 (d, *J* = 9.2 Hz, 2H), 7.64 (d, *J* = 9.2 Hz, 3H), 7.51 (d, *J* = 8.0 Hz, 2H), 7.35 (d, *J* = 8.0 Hz, 2H), 7.23--7.15 (m, 2H), 7.05 (d, *J* = 8.8 Hz, 2H), 6.61 (d, *J* = 9.2 Hz, 2H), 6.33 (s, 1H), 5.87 (s, 1H), 3.97 (s, 3H), 3.61 (s, 3H), 3.13 (s, 3H), 2.79--2.73 (m, 2H), 1.32 (t, *J* = 7.6 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 163.6, 147.6, 147.5, 146.9, 139.4, 137.5, 137.1, 135.1, 132.2, 130.6, 130.3, 129.7, 129.1, 128.9, 128.7, 127.2, 126.8, 126.1, 123.1, 114.3, 114.0, 69.0, 55.8, 55.5, 54.5, 28.9, 15.2. IR (film, ν, cm^--1^) 2964, 2833, 1594, 1497, 1332, 1320, 1145, 1083, 832. HR-MS (ESI) *m*/*z* calcd for C~35~H~31~ClN~2~NaO~7~S~2~ \[M + Na\]^+^ 713.1159, found 713.1158.

### (*E*)-1-(4-(*tert*-Butyl)phenyl)-7-chloro-5-methoxy-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4q**, Major) {#sec3.3.17}

155 mg, 54%; red solid, mp 166--167 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.80 (d, *J* = 9.2 Hz, 2H), 7.67--7.61 (m, 3H), 7.53 (s, 4H), 7.23--7.17 (m, 2H), 7.06 (d, *J* = 9.2 Hz, 2H), 6.62 (d, *J* = 9.2 Hz, 2H), 6.33 (s, 1H), 5.88 (s, 1H), 3.97 (s, 3H), 3.62 (s, 3H), 3.14 (s, 3H), 1.39 (s, 9H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 163.6, 154.5, 147.5, 147.0, 139.4, 137.5, 137.1, 135.1, 132.2, 130.6, 130.1, 129.7, 128.9, 128.7, 127.3, 126.8, 126.5, 126.1, 122.9, 114.3, 114.0, 69.0, 55.8, 55.5, 54.5, 35.0, 31.2. IR (film, ν, cm^--1^) 2953, 2841, 1595, 1501, 1458, 1336, 1263, 1145, 1083, 832. HR-MS (ESI) *m*/*z* calcd for C~37~H~35~ClN~2~NaO~7~S~2~ \[M + Na\]^+^ 741.1472, found 741.1471.

### (*E*)-7-Chloro-5-methoxy-1-(4-methoxyphenyl)-4-((4-methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4r**, Major) {#sec3.3.18}

169 mg, 61%; red solid, mp 179--180 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.78 (d, *J* = 8.8 Hz, 2H), 7.65--7.60 (m, 3H), 7.56 (d, *J* = 8.8 Hz, 2H), 7.25 (d, *J* = 8.4 Hz, 1H), 7.21--7.17 (m, 1H), 7.07--7.02 (m, 4H), 6.60 (d, *J* = 8.8 Hz, 2H), 6.32 (s, 1H), 5.86 (s, 1H), 3.96 (s, 3H), 3.90 (s, 3H), 3.59 (s, 3H), 3.14 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 163.6, 161.8, 147.4, 146.9, 139.1, 137.6, 137.0, 134.7, 132.2, 132.0, 130.6, 129.7, 128.8, 128.6, 127.2, 126.9, 126.1, 117.8, 115.1, 114.3, 114.0, 69.0, 55.8, 55.5, 54.6. IR (film, ν, cm^--1^) 2947, 2839, 1597, 1577, 1496, 1332, 1256, 1166, 837. HR-MS (ESI) *m*/*z* calcd for C~34~H~29~ClN~2~NaO~8~S~2~ \[M + Na\]^+^ 715.0952, found 715.0961.

### (*E*)-4-((4-Ethoxyphenyl)diazenyl)-3-((4-ethoxyphenyl)sulfonyl)-5-methoxy-1-phenyl-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4s**, Major) {#sec3.3.19}

136 mg, 52%; red solid, mp 180--181 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.79 (d, *J* = 8.8 Hz, 2H), 7.65--7.59 (m, 5H), 7.56--7.47 (m, 4H), 7.22--7.15 (m, 2H), 7.03 (d, *J* = 8.8 Hz, 2H), 6.57 (d, *J* = 8.8 Hz, 2H), 6.36 (s, 1H), 5.92 (s, 1H), 4.22--4.16 (m, 2H), 3.86--3.79 (m, 1H), 3.70--3.62 (m, 1H), 3.12 (s, 3H), 1.52 (t, *J* = 7.0 Hz, 3H), 1.34 (t, *J* = 7.0 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 163.8, 163.0, 148.1, 146.9, 138.7, 136.5, 135.8, 132.2, 131.1, 130.7(1), 130.7(6), 130.6, 129.8, 129.4, 128.2(4), 128.2(8), 127.7, 126.9, 126.4, 126.1, 114.7, 114.5, 114.4, 69.2, 64.1, 63.9, 54.2, 14.7, 14.4. IR (film, ν, cm^--1^) 2978, 2933, 1593, 1574, 1494, 1321, 1254, 1145, 835. HR-MS (ESI) *m*/*z* calcd for C~35~H~32~N~2~NaO~7~S~2~ \[M + Na\]^+^ 679.1549, found 679.1554.

### (*E*)-4-((4-Ethoxyphenyl)diazenyl)-3-((4-ethoxyphenyl)sulfonyl)-5-methoxy-1-(*p*-tolyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4t**, Major) {#sec3.3.20}

153 mg, 57%; red solid, mp 184--185 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.81--7.76 (m, 2H), 7.65--7.59 (m, 3H), 7.51--7.46 (m, 3H), 7.34--7.31 (m, 2H), 7.26 (d, *J* = 7.2 Hz, 1H), 7.22--7.16 (m, 1H), 7.05--7.01 (m, 2H), 6.55--6.58 (m, 2H), 6.34 (s, 1H), 5.92 (s, 1H), 4.22--4.16 (m, 2H), 3.86--3.78 (m, 1H), 3.70--3.63 (m, 1H), 3.11 (s, 3H), 2.46 (s, 3H), 1.52 (t, *J* = 7.0 Hz, 3H), 1.35 (t, *J* = 7.0 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 163.8, 162.9, 147.9, 146.9, 141.1, 140.0, 136.1, 135.7, 132.2, 131.0, 130.6, 130.4, 130.1, 129.9, 128.3, 128.2, 127.7, 126.9, 126.1, 123.3, 114.7, 114.4, 69.2, 64.1, 63.9, 54.1, 21.6, 14.7, 14.4. IR (film, ν, cm^--1^) 2981, 2931, 1599, 1574, 1494, 1322, 1254, 1146, 835. HR-MS (ESI) *m*/*z* calcd for C~36~H~34~N~2~NaO~7~S~2~ \[M + Na\]^+^ 693.1705, found 693.1708.

### (*E*)-4-((3,4-Dimethoxyphenyl)diazenyl)-3-((3,4-dimethoxyphenyl)sulfonyl)-5-methoxy-1-(*p*-tolyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4u**, Major) {#sec3.3.21}

174 mg, 62%; red solid, mp 187--188 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.63--7.59 (m, 2H), 7.46--7.44 (m, 3H), 7.40 (d, *J* = 2.0 Hz, 1H), 7.32 (s, 1H), 7.30 (s, 1H), 7.25--7.16 (m, 3H), 7.04 (d, *J* = 8.4 Hz, 1H), 6.96 (d, *J* = 2.4 Hz, 1H), 6.51 (d, *J* = 8.8 Hz, 1H), 6.39 (s, 1H), 5.94 (s, 1H), 4.05 (s, 3H), 4.04 (s, 3H), 3.68 (s, 3H), 3.44 (s, 3H), 3.13 (s, 3H), 2.46 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 154.0, 153.5, 149.7, 148.6, 148.0, 147.2, 141.3, 139.1, 135.9, 135.6, 131.0, 130.6, 130.3, 130.2, 130.0, 128.5, 128.4, 127.7, 126.9, 124.9, 123.1, 122.5, 111.8, 110.4, 110.2, 102.9, 69.2, 56.3, 56.2, 56.0, 55.8, 54.2, 21.6. IR (film, ν, cm^--1^) 2964, 2839, 1596, 1500, 1332, 1263, 1145, 1024, 832. HR-MS (ESI) *m*/*z* calcd for C~36~H~34~N~2~NaO~9~S~2~ \[M + Na\]^+^ 725.1603, found 725.1601.

### (*E*)-1-(4-Chlorophenyl)-5,7-dimethoxy-4-(*p*-tolyldiazenyl)-3-tosyl-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4v**, Major) {#sec3.3.22}

129 mg, 49%; red solid, mp 184--185 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.70 (d, *J* = 8.4 Hz, 2H), 7.60 (d, *J* = 8.4 Hz, 2H), 7.57--7.50 (m, 4H), 7.36 (d, *J* = 8.0 Hz, 2H), 7.16--7.13 (m, 2H), 6.96 (d, *J* = 8.0 Hz, 2H), 6.79--6.75 (m, 1H), 6.37 (s, 1H), 5.86 (s, 1H), 3.90 (s, 3H), 3.11 (s, 3H), 2.51 (s, 3H), 2.15 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 161.9, 150.6, 148.1, 145.9, 143.7, 138.0, 137.1, 136.7, 135.7, 133.0, 132.0, 130.7, 129.9, 129.8(2), 129.8(8), 129.5, 129.3, 125.0, 123.9, 120.1, 115.4, 114.8, 69.3, 55.6, 54.2, 21.7, 21.5. IR (film, ν, cm^--1^) 2969, 2862, 1598, 1483, 1334, 1326, 1170, 1090, 827. HR-MS (ESI) *m*/*z* calcd for C~34~H~29~ClN~2~NaO~6~S~2~ \[M + Na\]^+^ 683.1053, found 683.1055.

### (*E*)-1-(4-Ethylphenyl)-5-methoxy-4-(phenyldiazenyl)-3-(phenylsulfonyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4w**, Major) {#sec3.3.23}

102 mg, 43%; red solid, mp 162--163 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.89--7.84 (m, 2H), 7.82--7.78 (m, 2H), 7.64 (d, *J* = 7.6 Hz, 1H), 7.59--7.56 (m, 3H), 7.53--7.46 (m, 3H), 7.38--7.33 (m, 3H), 7.25--7.19 (m, 4H), 6.44 (s, 1H), 5.96 (s, 1H), 3.17 (s, 3H), 2.79--2.73 (m, 2H), 1.32 (t, *J* = 7.6 Hz, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 152.6, 148.3, 147.5, 139.6, 136.3, 136.0, 135.7, 134.5, 132.5, 131.2, 131.1, 130.7, 130.3, 130.1, 129.2, 129.0, 128.7, 128.3, 128.0, 127.8, 123.8, 123.2, 69.4, 54.5, 28.9, 15.2. IR (film, ν, cm^--1^) 2943, 2821, 1613, 1582, 1447, 1343, 1161, 1076, 776. HR-MS (ESI) *m*/*z* calcd for C~33~H~28~N~2~NaO~5~S~2~ \[M + Na\]^+^ 619.1337, found 619.1335.

### (*E*)-5,7-Dimethoxy-1-phenyl-4-(phenyldiazenyl)-3-(phenylsulfonyl)-3,5-dihydronaphtho\[1,2-*c*\]thiophene 2,2-dioxide (**4y**, Major) {#sec3.3.24}

115 mg, 48%; red solid, mp 163--164 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.88--7.84 (m, 2H), 7.80 (d, *J* = 8.0 Hz, 2H), 7.60--7.56 (m, 3H), 7.55--7.49 (m, 5H), 7.41--7.36 (m, 1H), 7.25--7.19 (m, 2H), 7.15 (d, *J* = 2.8 Hz, 1H), 7.08 (d, *J* = 8.8 Hz, 1H), 6.74--6.70 (m, 1H), 6.45 (s, 1H), 5.94 (s, 1H), 3.88 (s, 3H), 3.14 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 161.8, 152.6, 148.1, 137.8, 137.3, 136.3, 136.2, 134.5, 132.6, 131.4, 130.7, 130.5, 130.1, 129.4(1), 129.4(6), 129.2, 128.7, 126.4, 123.8, 123.6, 120.2, 115.2, 114.8, 69.3, 55.5, 54.1. IR (film, ν, cm^--1^) 3063, 2965, 1612, 1581, 1446, 1327, 1172, 1079, 780. HR-MS (ESI) *m*/*z* calcd for C~32~H~26~N~2~NaO~6~S~2~ \[M + Na\]^+^ 621.1130, found 621.1125.

### (*E*)-4-((4-Methoxyphenyl)diazenyl)-3-((4-methoxyphenyl)sulfonyl)-2,2-dioxido-1-phenyl-3,5-dihydronaphtho\[1,2-*c*\]thiophen-5-yl acetate (**4z**, Major) {#sec3.3.25}

144 mg, 55%; red solid, mp 178--179 °C; ^1^H NMR (400 MHz, CDCl~3~; δ, ppm) 7.83 (d, *J* = 7.6 Hz, 1H), 7.68 (d, *J* = 8.8 Hz, 1H), 7.58--7.51 (m, 4H), 7.49--7.39 (m, 6H), 7.23--7.18 (m, 1H), 7.04--6.99 (m, 2H), 6.75 (d, *J* = 8.4 Hz, 1H), 6.55 (d, *J* = 8.8 Hz, 1H), 6.40 (s, 1H), 6.21 (s, 1H), 3.96 (s, 3H), 3.66 (s, 3H), 3.59 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~; δ, ppm) 164.3, 164.1, 163.7, 146.3, 143.8, 138.2, 136.9, 132.2, 131.8, 131.7, 130.8, 130.7, 130.5, 129.4, 129.2, 128.9, 128.6, 127.5, 127.3, 127.1, 126.2, 126.0, 114.5, 114.2, 114.0, 65.0, 55.8, 55.5(1), 55.5(7). IR (film, ν, cm^--1^) 2933, 2840, 1637, 1617, 1594, 1496, 1320, 1263, 1144, 835. HR-MS (ESI) *m*/*z* calcd for C~34~H~28~N~2~NaO~8~S~2~ \[M + Na\]^+^ 679.1185, found 679.1182.
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